Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.

Urothelial Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations (INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Phase 2, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy (INCB 54828-202)

  • Details

ClinicalTrials.gov ID: NCT02924376
Diagnosis Type: NA
USOR Number: 16066

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Lymphomas

Clinical Trial at: Florida Cancer Affiliates - Ocala

A PHASE 3B RANDOMIZED STUDY OF LENALIDOMIDE (CC-5013) PLUS RITUXIMAB MAINTENANCE THERAPY FOLLOWED BY LENALIDOMIDE SINGLE-AGENT MAINTENANCE VERSUS RITUXIMAB MAINTENANCE IN SUBJECTS WITH RELAPSED/REFRACTORY FOLLICULAR, MARGINAL ZONE OR MANTLE CELL LYMPHOMA (CC-5013-NHL-008)(MAGNIFY)

  • Details

ClinicalTrials.gov ID: NCT01996865
Diagnosis Type: Non-Hodgkins
USOR Number: 13064

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Lung Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

CA209-817: A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Lung Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

CA209370: A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance after Induction Chemotherapy or as First-line Treatment Alone or in Combination with Standard of Care Therapies

  • Details

ClinicalTrials.gov ID: NCT02574078
Diagnosis Type: NSCLC
USOR Number: 14158

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Neuroendocrine Tumors

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Phase 3, Prospective, Randomized, Double-Blind, Multi-Center, Study of the Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg plus BSC vs. Placebo plus BSC for Tumour Control in Subjects with Well Differentiated, Metastatic and/or Unresectable Typical or Atypical Lung Neuroendocrine Tumours (Spinet) - Ipsen A-US-52030-328

  • Details

ClinicalTrials.gov ID: NCT02683941
Diagnosis Type: NA
USOR Number: 15079

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Pages